Deficiency of the Humoral immune Response to Measles Vaccine in Infants Immunized at Age 6 Months
Article Abstract:
Infants younger than one year may not benefit from measles vaccination because their immune system is not mature enough. Normally, children are vaccinated against measles at age 12 to 15 months but those under 12 months have the highest risk of severe illness from measles. In a study of 27 6-month-old infants, 26 9-month-old infants and 34 12-month-old infants who received the measles vaccine, only 36% of the 6-month-old infants achieved protective blood levels of antibodies against measles, compared to 100% of the other infants.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
Postlicensure effectiveness of varicella vaccine during an outbreak in a child care center
Article Abstract:
The varicella virus vaccine was highly effective in preventing chickenpox during an outbreak at a Georgia day-care center in 1996. In a retrospective study of 148 children, 55% developed varicella during the 15-week outbreak. The disease struck 88% of the 82 unvaccinated children and only 14% of the 66 who took the vaccin. Vaccinated children suffered milder illnesses. The vaccine was less effective in those with asthma. The varicella vaccine was effective in all cases at preventing moderate-to-severe chickenpox.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1997
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Leasing can put your practice in tune with technology. Internists push groups to merge. Don't run away from a colleague with substance abuse
- Abstracts: Detection of alcoholism in hospitalized children and their families. Relation of alcohol expectancies to changes in problem drinking among college students
- Abstracts: Bitter rain. A nurse in any language
- Abstracts: Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
- Abstracts: Adult-onset spinocerebellar dysfunction caused by a mutation in the gene for the alpha-tocopherol-transfer protein